Compare MXCT & RAIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MXCT | RAIL |
|---|---|---|
| Founded | 1999 | 1901 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Railroads |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 129.6M | 149.9M |
| IPO Year | 2021 | 2005 |
| Metric | MXCT | RAIL |
|---|---|---|
| Price | $1.18 | $7.36 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $5.50 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 125.0K |
| Earning Date | 05-12-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 134.94 |
| EPS | N/A | ★ 1.15 |
| Revenue | $33,026,000.00 | ★ $500,991,000.00 |
| Revenue This Year | N/A | $6.54 |
| Revenue Next Year | $18.50 | $30.90 |
| P/E Ratio | ★ N/A | $6.39 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.64 | $7.27 |
| 52 Week High | $2.38 | $14.90 |
| Indicator | MXCT | RAIL |
|---|---|---|
| Relative Strength Index (RSI) | 64.09 | 36.44 |
| Support Level | $0.77 | N/A |
| Resistance Level | $1.82 | $10.18 |
| Average True Range (ATR) | 0.09 | 0.26 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 60.00 | 3.85 |
MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.
FreightCar America Inc is a diversified manufacturer and supplier of railcars and railcar components. It designs and manufactures a variety of railcar types for transportation of bulk commodities and containerized freight products in North America. The company also provides railcar rebody and repair services, railcar conversion services, and supplies railcar parts. The company has two segments: Manufacturing and Aftermarket. The majority of the company's revenue is derived from the Manufacturing segment, which includes new railcar manufacturing, used railcar sales, and various conversions and rebodies. Geographically, it generates the maximum revenue from the United States.